Drug Type Interleukins |
Synonyms- |
Target |
Mechanism IL-2R agonists(Interleukin-2 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (01 Jan 2003), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Bladder Cancer | CN | 01 Jan 2003 | |
Breast Cancer | CN | 01 Jan 2003 | |
Liver Cancer | CN | 01 Jan 2003 | |
Lung Cancer | CN | 01 Jan 2003 | |
Lymphoma | CN | 01 Jan 2003 | |
Melanoma | CN | 01 Jan 2003 | |
Rectal Cancer | CN | 01 Jan 2003 | |
Renal Cell Carcinoma | CN | 01 Jan 2003 | |
Sjogren's Syndrome | CN | 01 Jan 2003 | |
Systemic Lupus Erythematosus | CN | 01 Jan 2003 |